Iconic Labs PLC Publication of a Prospectus (6917I)
08 Agosto 2023 - 8:58AM
UK Regulatory
TIDMICON
RNS Number : 6917I
Iconic Labs PLC
08 August 2023
8 August 2023
Iconic Labs PLC
("Iconic" or the "Company")
Publication of Prospectus and Issue of Equity
Iconic Labs PLC (LSE: ICON) today announces the publication of
its Prospectus (the "Prospectus") to shareholders. The Prospectus
gives Iconic the ability to issue Ordinary Shares as it finalises
its overall restructuring obligations. These shares will be
available to meet obligations towards:
-- the European High Growth Opportunities Securitization Fund
("EHGOSF") and Linton Capital LLP under the 23 August 2022
Settlement Deed;
-- the unsecured creditors under the 22 September 2022 Company Voluntary Agreement;
-- EHGOSF under the 28 September 2022 GBP3 million financing facility; and
-- management for outstanding fees.
The Prospectus has been approved by the Financial Conduct
Authority and is available to view on the Company's website:
https://www.iconiclabs.co.uk/documents/ and at the National Storage
Mechanism: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
.
Brad Taylor, Chief Executive Officer of Iconic Labs,
commented:
"We are pleased to announce the publication of the Company's
Prospectus as we near the completion of this complex two-year
restructuring process. Critically, the Prospectus also enables us
to access the next tranches of financing with EHGOSF so that Iconic
can finally shift its focus from the mechanics of restructuring to
generating shareholder value.
"With a highly experienced team based in the US, UK and Europe,
we are well-positioned to explore strategic acquisition options,
which may include the possibility of an RTO, and the development of
our current media business including owned brands such as GSN.
"The Board looks forward to updating the market in due
course."
- Ends -
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with
the Company's obligations under Article 17 of MAR.
For more information, please contact:
Iconic Labs Tel: +44 (0) 7462 156238
Brad Taylor, Chief Executive
Officer
Novum Securities Limited Tel: +44 (0) 20 7399 9400
David Coffman / Daniel
Harris
Yellow Jersey PR Tel: +44 (0) 20 3004 9512
Sarah Hollins iconic@yellowjerseypr.com
Annabelle Wills
Bessie Elliot
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PDINKFBPNBKDPFK
(END) Dow Jones Newswires
August 08, 2023 09:58 ET (13:58 GMT)
Iconic Labs (LSE:ICON)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Iconic Labs (LSE:ICON)
Gráfica de Acción Histórica
De May 2023 a May 2024